A meta-analysis of the impact of EPC capture stent on the clinical outcomes in patients with coronary artery disease.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of interventional cardiology

• Publication date

  2013-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1540-8183.2013.12017.xPMID 23383609
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Coronary microvascular function and cortical pain processing in patients with silent positive exercise testing and normal coronary arteries.

  2012cited by this paper
• 1-year outcome of TRIAS HR (TRI-stent adjudication study-high risk of restenosis) a multicenter, randomized trial comparing genous endothelial progenitor cell capturing stents with drug-eluting stents.

  2011cited by this paper
• Prospective randomised trial evaluating a paclitaxel-coated balloon in patients treated with endothelial progenitor cell capturing stents for de novo coronary artery disease

  2011cited by this paper
• Two‐year follow‐up of the genous™ endothelial progenitor cell capturing stent versus the taxus liberté stent in patients with De Novo coronary artery lesions with a high‐risk of restenosis

  2011cited by this paper
• Endothelial progenitor cell capturing stent and short dual antiplatelet therapy in patients on chronic anti-vitamin k regimen undergoing percutaneous coronary interventions: long-term outcomes of a single centre registry.

  2011cited by this paper
• Rationale and results of percutaneous coronary revascularization with endothelial progenitor cell capture stent in high-risk patients requiring undeferrable non-cardiac surgery.

  2011cited by this paper
• Two-year clinical registry follow-up of endothelial progenitor cell capture stent versus sirolimus-eluting bioabsorbable polymer-coated stent versus bare metal stents in patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction.

  2010cited by this paper
• DRUG-ELUTING STENTS FOR THE TREATMENT OF LEFT MAIN CORONARY ARTERY DISEASE WITH SIROLIMUS, PACLITAXEL, ZOTAROLIMUS, BIOLIMUSA9, EPC CAPTURE AND EVEROLIMUS-ELUTING STENT: MULTICENTER REGISTRY IN ASIA

  2010cited by this paper
• One-year clinical outcome after provisional T-stenting for bifurcation lesions with the endothelial progenitor cell capturing stent compared with the bare-metal stent.

  2010cited by this paper
• Drug-eluting versus bare-metal stents in large coronary arteries.

  2010cited by this paper
• CORONARY ARTERY DISEASE Original Studies Randomized Comparison of Endothelial Progenitor Cells Capture Stent Versus Cobalt-Chromium Stent for Treatment of ST-Elevation Myocardial Infarction. Six-Month Clinical, Angiographic, and IVUS Follow-Up

  2010cited by this paper
• Potential use of endothelial progenitor cells for regeneration of the vasculature

  2009cited by this paper
• Genous™ endothelial progenitor cell capturing stent vs. the Taxus Liberté stent in patients with de novo coronary lesions with a high-risk of coronary restenosis: a randomized, single-centre, pilot study

  2009cited by this paper
• Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events and restenosis in patients undergoing coronary stent implantation: a prospective study

  2008cited by this paper
• Drug-eluting or bare-metal stents for acute myocardial infarction.

  2008cited by this paper
• Percutaneous coronary intervention utilizing a new endothelial progenitor cells antibody‐coated stent: A prospective single‐center registry in high‐risk patients

  2008cited by this paper
• Stent thrombosis redux--the FDA perspective.

  2007cited by this paper
• Pathological Correlates of Late Drug-Eluting Stent Thrombosis: Strut Coverage as a Marker of Endothelialization

  2007cited by this paper
• Endothelial dysfunction and restenosis following percutaneous coronary intervention.

  2007cited by this paper
• Pathophysiology of coronary artery in‐stent restenosis

  2007cited by this paper
• Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk.

  2006cited by this paper
• Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture).

  2006cited by this paper
• Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents.

  2006cited by this paper
• Pathophysiology of Coronary Artery Disease

  2005cited by this paper
• Endothelial progenitor cell capture by stents coated with antibody against CD34: the HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth-First In Man) Registry.

  2005cited by this paper
• Circulating endothelial progenitor cells, vascular function, and cardiovascular risk.

  2003cited by this paper
• Endothelial progenitor cells: new hope for a broken heart.

  2003cited by this paper
• CD31 (PECAM‐1)‐bright cells derived from AC133‐positive cells in human peripheral blood as endothelial‐precursor cells

  2003cited by this paper
• Endothelial cell seeding influences lesion development following arterial injury in the cholesterol-fed rabbit.

  2002cited by this paper
• Bone-marrow-derived cells contribute to endothelial repair after thrombotic microangiopathy.

  2002cited by this paper
• Statin Therapy Accelerates Reendothelialization: A Novel Effect Involving Mobilization and Incorporation of Bone Marrow-Derived Endothelial Progenitor Cells

  2002cited by this paper
• Circulating Microparticles From Patients With Myocardial Infarction Cause Endothelial Dysfunction

  2001cited by this paper
• Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors.

  2000cited by this paper
• Atherosclerosis : Vascular biology

  2000cited by this paper
• Extent and direction of arterial remodeling in stable versus unstable coronary syndromes : an intravascular ultrasound study.

  2000cited by this paper
• In vitro differentiation of endothelial cells from AC133-positive progenitor cells

  2000cited by this paper
• Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization.

  1999cited by this paper
• In vitro differentiation of endothelial cells from AC133-positive progenitor cells.

  1999cited by this paper
• Embryonic stem cells differentiate in vitro to endothelial cells through successive maturation steps.

  1996cited by this paper
• Endothelial cell recoverage and intimal hyperplasia after endothelium removal with or without smooth muscle cell necrosis in the rabbit carotid artery.

  1996cited by this paper
• Vascular endothelial growth factor (VEGF) and VEGF receptor 2 (flk-1) are expressed during vasculogenesis and vascular differentiation in the quail embryo.

  1995cited by this paper
• The pathogenesis of atherosclerosis: a perspective for the 1990s

  1993cited by this paper
• Intimal healing. The pattern of reendothelialization and intimal thickening.

  1977cited by this paper
• DNA Synthesis and Mitoses in Coronary Collateral Vessels of the Dog

  1971cited by this paper

• Camouflaging endovascular stents with an endothelial coat using CD31 domain 1 and 2 mimetic peptides

  2024cites this paper
• The Importance of Antibacterial Surfaces in Biomedical Applications

  2018cites this paper
• Device thrombosis and pre-clinical blood flow models for assessing antithrombogenic efficacy of drug-device combinations.

  2017cites this paper
• In vitro and in vivo cell-capture strategies using cardiac stent technology - A review.

  2016cites this paper
• Capturing VE-Cadherin-Positive Endothelial Progenitor Cells for in-stent Vascular Repair.

  2016cites this paper
• Fabrication of endothelial progenitor cell capture surface via DNA aptamer modifying dopamine/polyethyleneimine copolymer film

  2016cites this paper
• Functional characterization of the transcription factor early growth response 1 (Egr1) in arteriogenesis

  2014cites this paper
• Surface-Bound Vascular Endothelial Growth Factor Promotes Prolonged Activation of Endothelial Cells: A New Technology for Capturing Endothelial Progenitor Cells by Intravascular Stents

  2014cites this paper
• MicroRNA-132 may play a role in coexistence of depression and cardiovascular disease: A hypothesis

  2013cites this paper
• Peri-procedural tight glycemic control during early percutaneous coronary intervention up-regulates endothelial progenitor cell level and differentiation during acute ST-elevation myocardial infarction: effects on myocardial salvage.

  2013cites this paper